Skip to main content

Month: September 2020

MiMedx Announces Preliminary Third Quarter 2020 Net Sales

Third Quarter 2020 Net Sales Expected to be Between $61 Million – $64 MillionLatest Corporate Presentation Filed with SEC and Posted to IR Website2020 Annual Meeting of Shareholders to be Held on November 20, 2020MARIETTA, Ga., Sept. 21, 2020 (GLOBE NEWSWIRE) — MiMedx Group, Inc., (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and a therapeutic biologics company, today provided guidance regarding certain unaudited, preliminary third quarter financial results. Net sales for the quarter ended September 30, 2020, are expected to be between $61 million and $64 million. This compares to $88.9 million reported for the quarter ended September 30, 2019. Net sales for the quarter ended September 30, 2019, include a benefit of $21.5 million resulting from a change in the Company’s methods for...

Continue reading

PINTEC Announces First Half 2020 Unaudited Financial Results

BEIJING, Sept. 21, 2020 (GLOBE NEWSWIRE) — Pintec Technology Holdings Limited (NASDAQ: PT) (“PINTEC” or the “Company”), a leading independent technology platform enabling financial services in China, today announced its unaudited financial results for the six months ended June 30, 2020.First Half 2020 Financial HighlightsTotal revenues decreased by 65.0% to RMB251.6million (US$35.6million) from RMB719.7 million in the same period of 2019.Gross profit was RMB42.7 million (US$6.0 million) compared to RMB296.9 million in the same period of 2019. Gross margin was 17.0% compared to 41.3% in the same period of 2019.Operating loss was RMB100.0 million (US$14.2 million) compared to operating income of RMB73.6 million in the same period of 2019.Net loss was RMB104.2 million (US$14.7 million) compared to net income of RMB81.2 million in the...

Continue reading

IMB Bank Selects Virtusa for Open Banking Compliance in Australia

SOUTHBOROUGH, Mass., Sept. 21, 2020 (GLOBE NEWSWIRE) — Virtusa Corporation (NASDAQ GS: VRTU), a global provider of digital strategy, digital engineering, IT services and solutions that help clients change and disrupt markets through innovation engineering, today announced that its CDR (Consumer Data Right) Solution has been selected by IMB Bank to assure the bank is compliant with the Australia Competition and Consumer Commission (ACCC) CDR regulations for open banking.To support compliance by IMB Bank, Virtusa’s CDR solution leverages elements of its Open Innovation Platform (OIP) as well as components of WSO2 API Management and Identity & Access Management.Through the CDR, the Australian Government has mandated that consumers have greater access to and control over their data. It will improve consumers’ ability to compare...

Continue reading

Texas Mineral Resources Consortium Awarded U.S. Department of Energy (DOE) Grant Targeting the Production of Mixed Rare Earth Oxides from Pennsylvania Coal-Based Resources

SIERRA BLANCA, TX, Sept. 21, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE ‒ Texas Mineral Resources Corp. (OTCQB: TMRC)DOE award is for potential value of $1 million [1]Project partners are Penn State University, Jeddo Coal and H22OSFull project plans production of 1-3 metric tons/day mixed rare earth oxides followed by final processing at USA Rare Earth facilitySuccessful completion heralds potentially significant economic benefits to regionGrant objective furthers effort to construct a complete U.S.-based REE supply chainAward is TMRC’s third U.S. Government grant[1] https://govtribe.com/opportunity/federal-contract-opportunity/production-of-mixed-rare-earth-oxides-reos-from-coal-based-resources-89243320rfe000032-1Texas Mineral Resources Corp. (“TMRC”), an exploration company which is developing its Round Top heavy rare earth critical...

Continue reading

Kraken Completes Successful Sea Trials of SeaScout® System Onboard Ocean Seeker

ST. JOHN’S, Newfoundland, Sept. 21, 2020 (GLOBE NEWSWIRE) — Kraken Robotics Inc. (TSX-V: PNG, OTCQB: KRKNF), Canada’s Ocean Company, is pleased to announce that it has successfully completed over 3 weeks of sea trials in Nova Scotia with our SeaScout® system installed on the company’s research and survey vessel, ‘Ocean Seeker’.The SeaScout® system consists of the Kraken’s Autonomous Launch and Recovery System (ALARS), Tentacle Winch® and, the KATFISH™ towed Synthetic Aperture Sonar underwater vehicle. Both the Tentacle Winch® and the ALARS are constructed of non-welded aluminum for high strength, low weight, and low magnetic signature. These properties are important for small host vehicles such as Unmanned Surface Vehicles (USVs) and Mine Counter Measures (MCM) vessels. The Tentacle Winch and ALARS are the culmination of an internal...

Continue reading

Power REIT Acquires Property for Greenhouse Cultivation of Cannabis in Highly Accretive Transaction

Tenant Implements State-Of-The-Art Aeroponics Growing SystemOld Bethpage, New York, Sept. 21, 2020 (GLOBE NEWSWIRE) — Power REIT (NYSE-AMEX: PW and PW.PRA) (“Power REIT” or the “Trust”) today announced that it has completed the acquisition of a 4.32 acre land parcel (“Tamarack 7”) for $150,000 located in southern Colorado through a wholly owned subsidiary (“PropCo”) which plans to construct a greenhouse for the cultivation of medical cannabis. Tamarack 7 is adjacent to several other properties that Power REIT currently owns in a Crowley County, Colorado and is approved for cannabis cultivation.Concurrent with the closing on this acquisition, PropCo entered into a “triple-net” lease that requires its tenant (“Fifth Ace”) to pay all property related expenses including maintenance, insurance and taxes. The lease has a term of 20 years...

Continue reading

Exercise of Warrants & Issue of Ordinary Shares and Total Voting Rights

AMRYT PHARMA PLC(“Amryt” or the “Company”)Exercise of Warrants & Issue of Ordinary Shares and Total Voting RightsDUBLIN, Ireland, and Boston MA, September 21 2020, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from serious and life-threatening rare diseases, announces that an institutional investor has exercised subscription rights relating to 4,229,753 zero cost warrants (the “Warrants”).These Warrants were issued in September 2019 as part of the Company’s acquisition of Aegerion.  Certain institutional investors elected to receive Warrants to subscribe for new ordinary shares of £0.06 each (“Ordinary Shares”), in place of the same number of Ordinary Shares, as consideration for the Company’s acquisition...

Continue reading

Mercury Marine continues its growth as outboards will be offered on select Sportsman models for the first time

FOND DU LAC, Wisc., Sept. 21, 2020 (GLOBE NEWSWIRE) — Mercury Marine, a division of Brunswick Corporation (NYSE: BC), is pleased to announce that Mercury outboard engines, including the 350 and 400 Verados and other high horsepower Mercury outboards, will be offered for the first time on nine Sportsman models beginning on November 1.  Mercury has continued to grow its presence in key saltwater markets and customers from around the U.S. have been asking for higher horsepower and requesting Mercury outboards.  Sportsman, their dealers, and many other key saltwater OEM’s, are now giving their customers the opportunity to experience the power and reliability of Mercury.“We were extremely excited to hear Sportsman and Mercury are working together and we can start offering Mercury engines on Sportsman boats to our customers,” said Bill...

Continue reading

The German Sleep Society (DGSM) Recognizes PAT™ based Technology in its New Sleep-Related Breathing Disorders Guidelines, Further Benefitting Itamar Medical’s Approach to Sleep Apnea Diagnosis

CAESAREA, Israel, Sept. 21, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the diagnosis of sleep apnea and other respiratory sleep disorders, is pleased to report that The German Sleep Society (DGSM) has released an update to its clinical guidelines for Sleep-Related Breathing Disorders (SRBD) recognizing Peripheral Arterial Tonometry (PAT™) technology as an equivalent alternative to polygraphy-based Home Sleep Apnea Testing (HSAT) systems. The new guidelines were published in Somnologie Magazine on September 9th, 2020.These guidelines set the specifications for accepted technologies and practices to be used in the diagnosis and treatment of SRBD, marking another major achievement in the recognition and adoption of PAT™ technology and PAT-based...

Continue reading

ASLAN Pharmaceuticals Completes Enrolment in Second Cohort and Opens New Sites in US and Australia in ASLAN004 Atopic Dermatitis Study

SINGAPORE, Sept. 21, 2020 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that clinical sites in the US and Australia are now open and ready to enrol patients into its multiple ascending dose (MAD) study testing the first-in-class therapeutic antibody ASLAN004 in moderate to severe atopic dermatitis (AD) patients. Patients will now be recruited from 4 sites in Australia, 3 sites in the US alongside 2 existing sites in Singapore.ASLAN recently restarted recruitment into the second cohort of the randomised, double blind, placebo-controlled study in Singapore following the lifting of government restrictions in response to COVID-19. All 8 patients have now been fully recruited...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.